SCHEMBL2232383

SCHEMBL2232383

CN(C(N)=S)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
FAAH O00519 1/20 0.59
PHGDH O43175 1/20 0.59
MGLL Q99685 1/20 0.59
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA9 Q16790 1/20 0.59
LMNA P02545 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 1/20 0.46
SIGMAR1 Q99720 1/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 2/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
POLB P06746 1/20 0.41
PLAU P00749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848450 0.80 FAAH (0.64) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL25137386 0.80 FAAH (0.64) ALDH1A1FAAHPHGDHMGLLCA12
Quinoline SCHEMBL29113186 0.80 ALDH1A1 (0.52) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL11692693 0.79 ALDH1A1 (0.48) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL25920874 0.79 ALDH1A1 (0.42) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL25920887 0.79 ALDH1A1 (0.52) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL5961342 0.78 FAAH (0.61) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL2979996 0.77 KMT2A (0.44) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL11371559 0.77 ALDH1A1 (0.40) ALDH1A1FAAHPHGDHMGLLCA12
SCHEMBL8661742 0.77 FAAH (0.55) ALDH1A1FAAHPHGDHMGLLCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115449136-B Accelerator composition of rubber nanocomposite as well as preparation method and application thereof 浙江大学 2024-02-27 CN claimed
CN-115125593-B Application of chelating agent in PCB preparation 生益电子股份有限公司 2023-12-05 CN claimed
CN-116731654-A Low-temperature quick-curing epoxy adhesive and preparation method thereof 成都拓利科技股份有限公司 2023-09-12 CN claimed
CN-115449136-A Accelerator composition of rubber nanocomposite and preparation method and application thereof 浙江大学 2022-12-09 CN claimed
CN-115125593-A Application of chelating agent in PCB preparation 生益电子股份有限公司 2022-09-30 CN claimed
CN-107486140-A Attapulgite adsorbing material for solidifying chromium in river bottom mud and preparation method thereof 北京清水润土环保科技有限公司 2017-12-19 CN claimed
CN-1291981-C Method for preparing 3-methyl-2-benzothiazolinone hydrazone and its hydrochloride UNIV FUDAN (CN) 2006-12-27 CN claimed
US-7153411-B2 Method for cleaning and polishing metallic alloys and articles cleaned or polished thereby BOSTON SCIENTIFIC SCIMED, INC. (US) 2006-12-26 US claimed
CN-1634900-A Method for preparing 3-methyl-2-benzothiazolinone hydrazone and its hydrochloride UNIV FUDAN (CN) 2005-07-06 CN claimed
US-20040192930-A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation G.D. SEARLE & CO. (US) 2004-09-30 US claimed
EP-0923933-B1 Substituted pyrazolyl benzenesulfonamides for use in the treatment of inflammation SEARLE & CO (US) 2002-07-03 EP claimed
EP-0923933-A1 Substituted pyrazolyl benzenesulfonamides for use in the treatment of inflammation G.D. SEARLE & CO. (US) 1999-06-23 EP claimed
EP-0854723-A1 SUBSTITUTED PYRAZOLYL BENZENESULFONAMIDES FOR USE IN VETERINARY THERAPIES AS ANTIINFLAMMATORY AGENTS G.D. SEARLE & CO. (US) 1998-07-29 EP claimed
WO-1997011704-A1 SUBSTITUTED PYRAZOLYL BENZENESULFONAMIDES FOR USE IN VETERINARY THERAPIES AS ANTIINFLAMMATORY AGENTS G.D. SEARLE & CO. (US) 1997-04-03 WO claimed
EP-0731795-A1 SUBSTITUTED PYRAZOLYL BENZENESULFONAMIDES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP claimed
WO-1995015316-A1 SUBSTITUTED PYRAZOLYL BENZENESULFONAMIDES FOR THE TREATMENT OF INFLAMMATION G. D. SEARLE & CO. (US) 1995-06-08 WO claimed
CN-115449136-B Accelerator composition of rubber nanocomposite as well as preparation method and application thereof 浙江大学 2024-02-27 CN disclosed
CN-115125593-B Application of chelating agent in PCB preparation 生益电子股份有限公司 2023-12-05 CN disclosed
US-4252963-A CYCLIZATION OF PHENYLTHIOUREAS WITH THIONYL CHLORIDE HOECHST AKTIENGESELLSCHAFT (DE) 1981-02-24 US disclosed
US-4113732-A CATALYTIC OXIDATIVE CYCLIZATION, CHLORINE AS OXIDIZER BASF AKTIENGESELLSCHAFT (DE) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192930-A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation IL6, HRH4, CCR2 ALDH1A1 1964/4885FAAH 301/4885PHGDH 3285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.